AI Article Synopsis
- A 62-year-old man with prostate cancer was evaluated using both F-PSMA-1007 and F-fluorocholine PET/CT scans for biochemical recurrence.
- The F-PSMA-1007 scan was better at identifying lymph node metastases in the pelvis and retroperitoneum compared to F-fluorocholine and revealed an area of increased activity in the spleen.
- The increased uptake in the spleen was linked to a previously identified splenic hemangioma, indicating the importance of understanding different imaging features to avoid misinterpretations in PET/CT reports.
Article Abstract
A 62-year-old man with prostate cancer underwent both F-PSMA-1007 and F-fluorocholine PET/CT studies for biochemical recurrence. F-PSMA-1007 PET/CT outperformed F-fluorocholine PET/CT in detecting lymph node metastases in the pelvis and retroperitoneum, whereas the former showed a focus of increased uptake in the spleen not seen on F-fluorocholine. The F-PSMA-1007 -avid lesion corresponded to a splenic hemangioma, which was initially detected in an MRI scan 10 years ago, unchanged in size. This case shows different features of F-PSMA-1007 and F-fluorocholine uptake, in an incidentally detected splenic hemangioma, alerting PET/CT reports for possible pitfall.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/RLU.0000000000003310 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!